HTIM
BMY icon

Harbour Trust & Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Harbour Trust & Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,348
Closed -$398K – 160
2024
Q1 		$398K Sell
7,348
-317
-4% -$16.1K 0.05% 130
2023
Q4 		$393K Buy
+7,665
New +$402K 0.06% 128

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbour Trust & Investment Management's BMY Position: Q2 2024 in Review

Harbour Trust & Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 7,348 shares — an estimated $398K sold.

Harbour Trust & Investment Management first reported a position in BMY in Q4 2023 and held it in 2 quarters. The position peaked at $398K in Q1 2024. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Harbour Trust & Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Harbour Trust & Investment Management sold 7,348 Bristol-Myers Squibb shares in Q2 2024, an estimated $398K.
  • Harbour Trust & Investment Management first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 2 quarters.
  • Harbour Trust & Investment Management's Bristol-Myers Squibb position peaked at $398K in Q1 2024.
  • 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2024, filed 23 Jul 2024.